A review of Nanoparticles in Drug Delivery: Recent advances and Future Prospects

Abstract

Current research into the use of modified nanoparticles in drug delivery systems (DDSs) for therapeutic applications has yielded numerous fascinating nanocarriers. This study investigates the various traditional and modern conveyance techniques for pharmaceutical distribution. Because of the serious drawbacks of traditional DDSs, nanocarriers have garnered extensive attention. Nanocarriers, including polymeric nanoparticles, mesoporous nanoparticles, nanomaterials, carbon nanotubes, dendrimers, liposomes, metallic nanoparticles, nanomedicine, and tailored nanomaterials, are used as transport systems for targeted distribution to specific body regions. Nanomedicine has rapidly grown to treat a wide range of conditions, including brain cancer, lung cancer, breast cancer, cardiovascular illness, and many others. All of these nanocarriers have been studied both in vitro and in vivo. Nanomedicines have the potential to significantly improve human health in the coming years by incorporating more modern techniques into the medication delivery system.